Invesco Ltd. Corcept Therapeutics Inc Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Invesco Ltd. holds 1,031,741 shares of CORT stock, worth $75.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,031,741

Previous 1,246,234 17.21%

Holding current value

$75.9 Million

Previous $142 Million 46.8%

% of portfolio

0.01%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$62.24 - $91.93 $13.4 Million - $19.7 Million	-214,493 Reduced 17.21%	1,031,741 $75.7 Million
Q1 2025 May 12, 2025	BUY	$49.85 - $114.22 $26.9 Million - $61.7 Million	540,101 Added 76.49%	1,246,234 $142 Million
Q4 2024 Feb 13, 2025	SELL	$44.66 - $60.85 $6.75 Million - $9.2 Million	-151,225 Reduced 17.64%	706,133 $35.6 Million
Q3 2024 Nov 12, 2024	BUY	$29.51 - $46.26 $5.67 Million - $8.88 Million	192,001 Added 28.86%	857,358 $39.7 Million
Q2 2024 Aug 13, 2024	SELL	$22.21 - $34.48 $2.33 Million - $3.62 Million	-104,923 Reduced 13.62%	665,357 $21.6 Million
Q1 2024 May 14, 2024	BUY	$21.1 - $27.46 $1.97 Million - $2.56 Million	93,339 Added 13.79%	770,280 $19.4 Million
Q4 2023 Feb 12, 2024	SELL	$24.82 - $32.88 $6.69 Million - $8.86 Million	-269,488 Reduced 28.47%	676,941 $22 Million
Q3 2023 Nov 13, 2023	BUY	$21.97 - $33.8 $9,776 - $15,040	445 Added 0.05%	946,429 $25.8 Million
Q2 2023 Aug 11, 2023	SELL	$21.44 - $25.15 $3.16 Million - $3.7 Million	-147,229 Reduced 13.47%	945,984 $21 Million
Q1 2023 May 12, 2023	BUY	$19.2 - $24.47 $1.91 Million - $2.44 Million	99,610 Added 10.03%	1,093,213 $23.7 Million
Q4 2022 Feb 13, 2023	BUY	$19.95 - $29.96 $1.46 Million - $2.19 Million	73,178 Added 7.95%	993,603 $20.2 Million
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $7.4 Million - $8.72 Million	-299,606 Reduced 24.56%	920,425 $23.6 Million
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $2.4 Million - $3.51 Million	138,568 Added 12.81%	1,220,031 $29 Million
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $2,843 - $4,336	172 Added 0.02%	1,081,463 $24.4 Million
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $5.89 Million - $8.04 Million	-344,264 Reduced 24.15%	1,081,291 $21.4 Million
Q3 2021 Nov 15, 2021	BUY	$19.68 - $22.53 $3.1 Million - $3.55 Million	157,522 Added 12.42%	1,425,555 $28.1 Million
Q2 2021 Aug 17, 2021	BUY	$19.97 - $24.43 $2.5 Million - $3.06 Million	125,379 Added 10.97%	1,268,033 $27.9 Million
Q1 2021 May 17, 2021	BUY	$23.49 - $30.56 $224,587 - $292,184	9,561 Added 0.84%	1,142,654 $27.2 Million
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $19.9 Million - $32.4 Million	-1,185,902 Reduced 51.14%	1,133,093 $29.6 Million
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $12.1 Million - $19.4 Million	969,755 Added 71.87%	2,318,995 $40.4 Million
Q2 2020 Aug 14, 2020	SELL	$11.0 - $18.26 $184,217 - $305,800	-16,747 Reduced 1.23%	1,349,240 $22.7 Million
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $5.91 Million - $8.2 Million	-584,089 Reduced 29.95%	1,365,987 $16.2 Million
Q4 2019 Feb 14, 2020	BUY	$12.06 - $16.96 $6.45 Million - $9.07 Million	534,564 Added 37.76%	1,950,076 $23.6 Million
Q3 2019 Nov 14, 2019	SELL	$10.41 - $14.66 $4.27 Million - $6.01 Million	-409,900 Reduced 22.46%	1,415,512 $20 Million
Q2 2019 Aug 14, 2019	SELL	$9.78 - $12.76 $3.24 Million - $4.23 Million	-331,284 Reduced 15.36%	1,825,412 $20.4 Million
Q1 2019 May 15, 2019	SELL	$10.03 - $15.71 $294,882 - $461,874	-29,400 Reduced 1.34%	2,156,696 $25.3 Million
Q4 2018 Feb 14, 2019	BUY	$11.29 - $17.19 $24.7 Million - $37.6 Million	2,186,096 New	2,186,096 $29.2 Million

Others Institutions Holding CORT

# of Institutions

466

Shares Held

82.7M

Call Options Held

489K

Put Options Held

1.02M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.88B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account